Specific cancer immunotherapy adjunctive to surgery for advanced gastric cancer: a report of six long term survivors.
In order to improve the results with non-curatively resected advanced gastric cancer, we have tried specific cancer immunotherapy adjunctive to surgery. In this article, six long term survivors (median 6.2 years) are reported.
D000230:Adenocarcinoma / Q000601:surgery / Q000628:therapy*; D000231:Adenocarcinoma, Papillary / Q000601:surgery / Q000628:therapy; D000368:Aged; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D013274:Stomach Neoplasms / Q000601:surgery / Q000628:therapy*
D000951:Antigens, Neoplasm